LOTUSEYE.NS

Lotus Eye Hospital and Institute Limited

HealthcareMedical - Care FacilitiesININRPeers →Country macro →

$132.86

Jun 18, 2026

AI Brief

Market cap

$2.66B

52w range

—

P / E

—

EPS · FY 2026

$0.04

Volume

—

Revenue · FY 2026

$537.14M

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Lotus Eye Hospital and Institute Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$132.86

Change

+3.38%

Period high

$139.98

Period low

$98.22

Period start

$128.512026-02-01

Through 2026-06-18

Fair value

Football field →

Weighted blend

$0.59

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

LOTUSEYE.NS

132.86+3.38%

H 143.20L 97.59MA50 110.91MA200 —Avg vol 30K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Technology
+2.51%
Consumer Cyclical
+0.30%
Healthcare
+0.01%
Utilities
-0.07%
Financial Services
-0.24%
Consumer Defensive
-0.30%
Energy
-0.45%
Industrials
-0.48%
Communication Services
-0.55%
Basic Materials
-0.66%
Real Estate
-0.99%

Top industries (issuer's industry highlighted)

Medical - Care Facilities
-3.08%
Oil & Gas Energy
+8.53%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Electronic Gaming & Multimedia
+5.23%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Financial - Mortgages
+4.08%
Computer Hardware
-3.67%
Staffing & Employment Services
-3.62%
Internet Content & Information
+3.58%
Coal
-3.56%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for LOTUSEYE.NS.

Peers

No peer list available for LOTUSEYE.NS.

Total assets

$825.97M

Total debt

$158.34M

Cash & equiv

$38.27M

Operating CF

$24.15M

Free cash flow

-$106.28M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$537.14M	-$3.67M	$804K	$0.04	+0.15%